Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

Podobne zapisy

• Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping
  od: HUR, JOON YOUNG, i wsp.
  Wydane: (2020)
• Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
  od: Jung, Hyun Ae, i wsp.
  Wydane: (2020)
• Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors
  od: Kim, Hongsik, i wsp.
  Wydane: (2021)
• Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?
  od: Hyun Ae Jung, i wsp.
  Wydane: (2020-10-01)
• The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer
  od: Jung, Hyun Ae, i wsp.
  Wydane: (2020)